HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

The present invention encompasses compounds of the formula (I) wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of u...

Full description

Saved in:
Bibliographic Details
Main Authors TSCHANTZ, Matt Aaron, BOSANAC, Todd, SHEN, Yue, BURKE, Michael Jason, SOLEYMANZADEH, Fariba, BENTZIEN, Joerg, MAO, Wang, FRYER, Ryan Michael, MCKIBBEN, Bryan Patrick, LARSON, Eric Thomas
Format Patent
LanguageEnglish
French
Published 22.06.2017
Online AccessGet full text

Cover

More Information
Summary:The present invention encompasses compounds of the formula (I) wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use. La présente invention concerne des composés de formule (I) dans laquelle les groupes R1, Cy, et Y sont tels que définis ici, lesdits composés étant appropriés pour le traitement de maladies liées à la BTK. L'invention porte en outre sur un procédé de production de ces composés, sur des préparations pharmaceutiques contenant lesdits et sur leurs procédés d'utilisation.
Bibliography:Application Number: WO2016US66799